PP
MEDP icon

PDS Planning’s Medpace MEDP Stock Holding History

PDS Planning’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
2,368
-8
-0.3% -$3.69K 0.07% 127
2026
Q1 		$1.14M Buy
2,376
+2
+0.1% +$1.02K 0.08% 119
2025
Q4 		$1.33M Buy
2,374
+8
+0.3% +$4.54K 0.09% 105
2025
Q3 		$1.22M Sell
2,366
-55
-2% -$24K 0.08% 112
2025
Q2 		$760K Buy
2,421
+35
+1% +$10.5K 0.06% 166
2025
Q1 		$727K Buy
2,386
+9
+0.4% +$3.03K 0.06% 157
2024
Q4 		$790K Sell
2,377
-3
-0.1% -$1.02K 0.07% 120
2024
Q3 		$794K Buy
2,380
+23
+1% +$8.74K 0.07% 122
2024
Q2 		$971K Hold
2,357
– – 0.1% 87
2024
Q1 		$953K Buy
2,357
+3
+0.1% +$1.05K 0.1% 87
2023
Q4 		$722K Hold
2,354
– – 0.08% 98
2023
Q3 		$570K Hold
2,354
– – 0.07% 112
2023
Q2 		$565K Hold
2,354
– – 0.07% 113
2023
Q1 		$443K Hold
2,354
– – 0.06% 133
2022
Q4 		$500K Hold
2,354
– – 0.08% 96
2022
Q3 		$370K Hold
2,354
– – 0.07% 107
2022
Q2 		$352K Hold
2,354
– – 0.06% 121
2022
Q1 		$385K Sell
2,354
-366
-13% -$60.3K 0.07% 122
2021
Q4 		$592K Sell
2,720
-38
-1% -$7.96K 0.11% 81
2021
Q3 		$522K Hold
2,758
– – 0.12% 84
2021
Q2 		$487K Hold
2,758
– – 0.12% 87
2021
Q1 		$452K Hold
2,758
– – 0.13% 83
2020
Q4 		$384K Hold
2,758
– – 0.13% 85
2020
Q3 		$308K Sell
2,758
-17
-0.6% -$1.97K 0.13% 91
2020
Q2 		$258K Sell
2,775
-1
-0% -$85 0.12% 101
2020
Q1 		$204K Buy
2,776
+33
+1% +$2.87K 0.13% 91
2019
Q4 		$231K Buy
2,743
+7
+0.3% +$542 0.15% 87
2019
Q3 		$230K Buy
+2,736
New +$207K 0.16% 81

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

PDS Planning's MEDP Position: Q2 2026 in Review

PDS Planning reduced its Medpace (MEDP) stake by 0.34% in Q2 2026, selling an estimated $3.69K and leaving 2,368 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #127.

PDS Planning first reported a position in MEDP in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.33M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • PDS Planning held 2,368 shares of Medpace worth $1.25M as of Q2 2026.
  • PDS Planning sold 8 Medpace shares in Q2 2026, an estimated $3.69K.
  • Medpace made up 0.07% of PDS Planning's portfolio in Q2 2026, its #127 holding.
  • PDS Planning first reported a position in Medpace in Q3 2019 and has held it in 28 quarters since.
  • PDS Planning's Medpace position peaked at $1.33M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.